Leiv Lea | executive |
Richard Miller | executive |
Jeffrey Arcara | executive |
Jiayuan Gong | analyst |
Jeffrey Jones | analyst |
Liang Cheng | analyst |
Rosemary Li | analyst |
Good afternoon, everyone. Thank you for standing by, and welcome to the Corvus Pharmaceuticals Fourth Quarter and Full Year 2023 Business Update and Financial Results Conference Call. [Operator Instructions] It is now my pleasure to turn the call over to Zack Kubow of Real Chemistry. Please go ahead, sir.
Thank you, operator, and good afternoon, everyone.